483
ULTRAtab Laboratories, Inc.FDA 483 - ULTRAtab Laboratories, Inc. - February 01, 2019
Discuss this record with AI
Record Details
An FDA inspection of Vitratab Laboratories, Inc. in Highland, NY, from January 25 to February 1, 2019, revealed a significant quality control issue. The firm's master manufacturing record for dietary supplements failed to identify necessary specifications, specifically microbial limits, to ensure product quality. This indicates a deficiency in their manufacturing process controls.
Open in Dashboard
ID · 44a605d4-aa61-4044-a075-a2ce67bd620c